Business Insider

Seqirus Presents New Real-World Evidence on Relative Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Adults 65 Years and Older at IDWeek 2020

SUMMIT, N.J., Oct. 21, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today presented new real-world evidence (RWE) on the effectiveness of an MF59 ®-adjuvanted, trivalent ...
The New England Journal of Medicine

Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age

Quadrivalent recombinant influenza vaccines contain three times the amount of hemagglutinin protein as standard-dose egg-based vaccines, and the recombinant formulation is not susceptible to antigenic ...
ascopubs.org

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

BREATH: Web-Based Self-Management for Psychological Adjustment After Primary Breast Cancer—Results of a Multicenter Randomized Controlled Trial Patients diagnosed with early-stage invasive ductal ...
Healio

High-dose flu vaccine may benefit adults younger than age 65 years

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A recombinant flu vaccine had a relative effectiveness ...
Nasdaq

Seqirus Presents New Real-World Evidence Demonstrating Effectiveness of Cell-Based and Adjuvanted Seasonal Influenza Vaccines at IDWeek 2021

SUMMIT, N.J., Sept. 29, 2021 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX: CSL), today announced data supporting the effectiveness of both ...